Thirty-four drugs targeted by 21 of the 26 core genes (except IGF1, KNG1, PF4, SERPINA1 and TIMP1) may be potential therapeutic agents for renal insufficiency in geriatric multimorbidity patients. This evidence concerns the gene SERPINA1 and Renal insufficiency.